iBio Inc.

NASDAQ: IBIO · Real-Time Price · USD
0.74
0.06 (9.14%)
At close: Aug 15, 2025, 3:59 PM
0.75
1.47%
After-hours: Aug 15, 2025, 07:56 PM EDT

iBio Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
n/a 200K n/a 175K n/a n/a 50K n/a n/a n/a n/a 61K 1.94M 168K 211K 491K 765K 705K 410K
Cost of Revenue
n/a n/a n/a -744K 332K 387K 250K 31K 282K 299K n/a 15K 48K 113K 40K 187K 493K 211K 107K
Gross Profit
n/a 200K n/a 919K -332K -387K -200K -31K -282K -299K n/a 46K 1.9M 55K 171K 304K 272K 494K 303K
Operating Income
-4.88M -4.42M -4.11M -3.41M -3.63M -4.5M -5.1M -4.96M -6.17M -10.57M -7.64M -16.9M -12.18M -7.23M -8.97M -9.44M -7.2M -7.54M -6.92M
Interest Income
72K 112K 174K 223K 43K 42K 55K 50K 23K 41K 99K 67K 40K 35K 36K n/a 152K 27K 4K
Pretax Income
-4.86M -4.36M -3.99M -3.25M -2.63M -4.49M -5.07M -4.93M -6.28M -10.56M -7.54M -17.05M -12.39M -7.19M -5.19M 114K -7.66M -8.13M -7.53M
Net Income
-4.86M -4.36M -3.99M -7.78M -3.17M -8.21M -5.75M -6.03M -7.29M -33.55M -18.13M -17.05M -12.39M -11.92M -8.94M 116K -7.66M -8.13M -7.53M
Selling & General & Admin
2.97M 2.74M 2.8M 2.44M 2.72M 2.96M 3.55M 2.61M 3.52M 7.79M 5.09M 10.61M 5.32M 5.37M 4.17M 6.65M 5.31M 5.81M 5.57M
Research & Development
1.91M 1.88M 1.3M 1.14M 904K 1.53M 1.61M 2.36M 2.64M 2.78M 2.55M 6.34M 3.27M 1.86M 2.51M 3.1M 2.16M 2.44M 1.76M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a -98K n/a n/a -13K -48K -113K -40K n/a 1K 2K n/a
Operating Expenses
4.88M 4.62M 4.11M 3.58M 3.29M 4.5M 5.15M 4.96M 6.17M 10.57M 7.64M 16.94M 8.54M 7.12M 5.27M 9.74M 7.47M 8.25M 7.23M
Interest Expense
54K 57K 57K 60K 52K 34K 26K 17K 35K 31K n/a 225K n/a n/a 609K 656K 612K 615K 614K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.88M 4.62M 4.11M 3.58M 3.63M 4.5M 5.15M 4.96M 6.17M 10.57M 7.64M 16.96M 14.13M 11.81M 9.19M 9.93M 7.97M 8.25M 7.33M
Income Tax Expense
n/a n/a n/a n/a n/a 34K n/a n/a 35K n/a n/a 21.11M 208K n/a 608K n/a n/a 615K n/a
Shares Outstanding (Basic)
9.86M 9.13M 8.63M 8.62M 3.71M 1.86M 1.2M 1.02M 765.37K 490K 884.2K 872.7K 800.68K 718.07K 741.37K 435.75K 862.16K 752.35K 324.88K
Shares Outstanding (Diluted)
9.86M 9.13M 8.63M 8.62M 3.71M 1.86M 1.2M 1.02M 1.1M 490K 884.2K 872.7K 871.9K 871.5K 871.5K 434.04K 862.16K 752.35K 324.88K
EPS (Basic)
-0.49 -0.48 -0.46 -0.9 -0.85 -4.42 -4.79 -5.94 -11.07 -34.21 -20.5 -43.73 -14.45 -13.72 -20.6 0.13 -20 -20 -11.59
EPS (Diluted)
-0.49 -0.48 -0.46 -0.9 -0.85 -4.42 -4.8 -5.94 -11.07 -34.21 -41 -43.73 -14.45 -13.68 -20.6 0.13 -20 -20 -25
EBITDA
-4.53M -4.03M -3.65M -2.9M -2.25M -4.13M -4.8M -4.88M -5.96M -10.23M -7.04M -16.48M -5.75M -6.16M -4.42M -8.67M -6.45M -6.91M -6.34M
EBIT
-4.81M -4.31M -3.93M -3.19M -2.58M -4.45M -5.05M -4.92M -6.24M -10.53M -7.54M -16.83M -6.79M -7.23M -8.33M 727K -7.05M -7.52M -6.92M
Depreciation & Amortization
282K 281K 278K 281K 332K 319K 250K 305K 282K 299K 494K 354K 995K 787K 810K 630K 598K 602K 584K